Home Contact Sitemap

PedAM

Pediatric Disease Annotations & Medicines




Disease cardiomyopathy
Phenotype C0006142|breast cancer
Sentences 2
PubMedID- 23741376 Clinical studies have suggested no beneficial effect of metoprolol, a β1-ar blocker, in dox-treated lymphoma patients [15] but a beneficial effect of nebivolol, a β1-ar blocker associated to a β3-ar agonistic properties against anthracycline-induced cardiomyopathy in patients with breast cancer [55].
PubMedID- 21555361 Anthracycline-induced cardiomyopathy in siblings with early breast cancer.

Page: 1